Research article
Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies
-
* Corresponding author: Francisco J Esteva festeva@mdanderson.org
Breast Cancer Research 2005, 7:R436-R443 doi:10.1186/bcr1020
No comments have yet been made on this article.